How it works

1. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, Taylor DR. Diagnosing asthma - Comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004;169:473-8.

2. Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax 2003;58:494-9.

3. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of
acute asthma. Am J Respir Crit Care Med 1995;152:800-3.

4. Tsai YG, Lee MY, Yang KD, Chu DM, Yuh YS, Hung CH. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 2001;139:433-7.
5. Kharitonov SA. Exhaled markers of inflammatory lung diseases: ready for routine monitoring? Swiss Med Wkly 2004;134:175-92.

6. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, Herbison GP, Taylor DR. Exhaled Nitric Oxide A Predictor of Steroid Response. Am J Respir Crit Care 2005; 172:453-459.

7. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol
8. Silkoff PE, McClean PA, Spino M, Erlich L, Slutsky AS, Zamel N. Dose response relationship and reproducibility
of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001;119:1322-8.

9.Nordvall SL, Janson C, Alving K. Agreement between a stationary FENO system and the new hand-held FENO analyzer for FENO measurements in adults and children. World Allergy Congress. Munich 2005. Poster session 1, Poster No. 164.
10. Alving K, Jansson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res 2006;7:67.

11. Hemmingsson T, Linnarsson D, Gambert R. Novel Hand-held device for exhaled nitric oxide analysis in research and clinical applications. J Clin Moni Comput 2004;18:379-87.

12. Sovijärvi A, Järvinen H, Uusi-Simola J, Nikkinen P, Piirilä P. Accuracy and repeatability of a hand-held nitric oxide analyzer in adults with respiratory symptoms. ERS Annual Congress, Copenhagen 2005, Poster 3670.

13. Vahlkvist S, Sinding M, Skamstrup K, Bisgaard H. Daily home measurements of exhaled nitric oxide an asthmatic children during natural birch pollen exposure. J. Allergy Clin Immunol 2006;117:1272-1276.

14. Pijnenburg MW, Floor SI, Hop WC, De Jongste JC. Daily
ambulatory exhaled nitric oxide measurements in asthma. Pediatr Allergy Immunol 2006;17:189-193.

15. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care 2005;171:912-30.

NIOX MINO®  is CE-marked according to Medical Device Directive MDD 93/42/EEC and approved for clinical use in EEC countries. US Patent 5,447,165, US Patent 5,922,610, US Patent 6,038,913, US Patent 6,063,027, US Patent 6,099,480, US Patent 6,149,606, US Patent 6,183,416, US Patent 6,511,425, US Patent 6,626,844, US Patent 6,723,056, US Patent 6,761,185 and patents pending. NIOX MINO and NIOX are registered trademarks of Aerocrine AB.

- Improving management and care of patients with inflammatory disorders
Aerocrine AB, P.O. Box 1024, SE-171 21 Solna, Sweden.
Phone +46 8 629 07 80. Fax +46 8 629 07 81. E-mail info@aerocrine.com  www.aerocrine.com